A 0 1 0 1 O
second 2 8 2 8 O
malignancy 9 19 9 19 B-cancer
, 19 20 19 20 O
other 21 26 21 26 O
than 27 31 27 31 O
basal 32 37 32 37 B-cancer
cell 38 42 38 42 I-cancer
carcinoma 43 52 43 52 I-cancer
of 53 55 53 55 I-cancer
the 56 59 56 59 I-cancer
skin 60 64 60 64 I-cancer
or 65 67 65 67 O
in 68 70 68 70 O
situ 71 75 71 75 B-cancer
carcinoma 76 85 76 85 I-cancer
of 86 88 86 88 I-cancer
the 89 92 89 92 I-cancer
cervix 93 99 93 99 I-cancer
( 100 101 100 101 O
unless 101 107 101 107 O
for 108 111 108 111 O
other 112 117 112 117 O
tumor 118 123 118 123 B-cancer
type 124 128 124 128 O
patient 129 136 129 136 O
was 137 140 137 140 O
treated 141 148 141 148 O
with 149 153 149 153 O
curative 154 162 154 162 O
intent 163 169 163 169 O
at 170 172 170 172 O
least 173 178 173 178 O
2 179 180 179 180 B-lower_bound
years 181 186 181 186 I-lower_bound
previously 187 197 187 197 O
. 197 198 197 198 O
) 198 199 198 199 O

Able 0 4 200 204 O
to 5 7 205 207 O
take 8 12 208 212 O
aspirin 13 20 213 220 B-treatment
( 21 22 221 222 O
81 22 24 222 224 B-lower_bound
or 25 27 225 227 O
325 28 31 228 231 B-upper_bound
mg 32 34 232 234 I-upper_bound
) 34 35 234 235 O
daily 36 41 236 241 O
as 42 44 242 244 O
prophylactic 45 57 245 257 B-treatment
anti 58 62 258 262 I-treatment
- 62 63 262 263 I-treatment
coagulation 63 74 263 274 I-treatment
( 75 76 275 276 O
patients 76 84 276 284 O
intolerant 85 95 285 295 O
to 96 98 296 298 O
ASA 99 102 299 302 O
may 103 106 303 306 O
use 107 110 307 310 O
low 111 114 311 314 B-treatment
molecular 115 124 315 324 I-treatment
weight 125 131 325 331 I-treatment
heparin 132 139 332 339 I-treatment
) 139 140 339 340 O

Active 0 6 341 347 B-clinical_variable
, 6 7 347 348 I-clinical_variable
clinically 8 18 349 359 I-clinical_variable
serious 19 26 360 367 I-clinical_variable
infection 27 36 368 377 I-clinical_variable
> 37 38 378 379 O
CTCAE 39 44 380 385 B-lower_bound
grade 45 50 386 391 I-lower_bound
2 51 52 392 393 I-lower_bound

Age 0 3 394 397 B-age
greater 4 11 398 405 O
than 12 16 406 410 O
or 17 19 411 413 O
equal 20 25 414 419 O
to 26 28 420 422 O
18 29 31 423 425 B-lower_bound
years 32 37 426 431 I-lower_bound

All 0 3 432 435 O
study 4 9 436 441 O
participants 10 22 442 454 O
must 23 27 455 459 O
be 28 30 460 462 O
registered 31 41 463 473 O
into 42 46 474 478 O
the 47 50 479 482 O
mandatory 51 60 483 492 O
Revlimid 61 69 493 501 B-treatment
REMS 70 74 502 506 O
® 74 75 506 507 O
program 76 83 508 515 O
, 83 84 515 516 O
and 85 88 517 520 O
be 89 91 521 523 O
willing 92 99 524 531 O
and 100 103 532 535 O
able 104 108 536 540 O
to 109 111 541 543 O
comply 112 118 544 550 O
with 119 123 551 555 O
the 124 127 556 559 O
requirements 128 140 560 572 O
of 141 143 573 575 O
the 144 147 576 579 O
REMS 148 152 580 584 O
® 152 153 584 585 O
program 154 161 586 593 O

Any 0 3 594 597 O
other 4 9 598 603 O
cardiac 10 17 604 611 B-chronic_disease
condition 18 27 612 621 I-chronic_disease
that 28 32 622 626 O
, 32 33 626 627 O
in 34 36 628 630 O
the 37 40 631 634 O
opinion 41 48 635 642 O
of 49 51 643 645 O
the 52 55 646 649 O
treatment 56 65 650 659 O
physician 66 75 660 669 O
, 75 76 669 670 O
would 77 82 671 676 O
make 83 87 677 681 O
this 88 92 682 686 O
protocol 93 101 687 695 O
unreasonably 102 114 696 708 O
hazardous 115 124 709 718 O
for 125 128 719 722 O
the 129 132 723 726 O
patient 133 140 727 734 O

Central 0 7 735 742 B-chronic_disease
nervous 8 15 743 750 I-chronic_disease
system 16 22 751 757 I-chronic_disease
( 23 24 758 759 I-chronic_disease
CNS 24 27 759 762 I-chronic_disease
) 27 28 762 763 I-chronic_disease
involvement 29 40 764 775 O
by 41 43 776 778 O
lymphoma 44 52 779 787 B-cancer
at 53 55 788 790 O
time 56 60 791 795 O
of 61 63 796 798 O
enrollment 64 74 799 809 O

Concomitant 0 11 810 821 O
use 12 15 822 825 O
of 16 18 826 828 O
warfarin 19 27 829 837 B-treatment
or 28 30 838 840 O
other 31 36 841 846 O
Vit 37 40 847 850 B-treatment
K 41 42 851 852 I-treatment
antagonists 43 54 853 864 I-treatment

Eastern 0 7 865 872 B-clinical_variable
Cooperative 8 19 873 884 I-clinical_variable
Oncology 20 28 885 893 I-clinical_variable
Group 29 34 894 899 I-clinical_variable
Performance 35 46 900 911 I-clinical_variable
Status 47 53 912 918 I-clinical_variable
greater 54 61 919 926 O
than 62 66 927 931 O
2 67 68 932 933 B-lower_bound

Females 0 7 934 941 B-gender
of 8 10 942 944 O
childbearing 11 23 945 957 O
potential 24 33 958 967 O
( 34 35 968 969 O
FCBP 35 39 969 973 O
) 39 40 973 974 O
must 41 45 975 979 O
have 46 50 980 984 O
a 51 52 985 986 O
negative 53 61 987 995 B-pregnancy
serum 62 67 996 1001 I-pregnancy
or 68 70 1002 1004 I-pregnancy
urine 71 76 1005 1010 I-pregnancy
pregnancy 77 86 1011 1020 I-pregnancy
test 87 91 1021 1025 O

Females 0 7 1026 1033 B-gender
of 8 10 1034 1036 O
reproductive 11 23 1037 1049 O
potential 24 33 1050 1059 O
must 34 38 1060 1064 O
adhere 39 45 1065 1071 O
to 46 48 1072 1074 O
the 49 52 1075 1078 O
scheduled 53 62 1079 1088 O
pregnancy 63 72 1089 1098 B-pregnancy
testing 73 80 1099 1106 O
as 81 83 1107 1109 O
required 84 92 1110 1118 O
in 93 95 1119 1121 O
the 96 99 1122 1125 O
Revlimid 100 108 1126 1134 O
REMS 109 113 1135 1139 O
® 113 114 1139 1140 O
program 115 122 1141 1148 O

Hep 0 3 1149 1152 B-treatment
B 4 5 1153 1154 I-treatment
serology 6 14 1155 1163 I-treatment
positive 15 23 1164 1172 O
without 24 31 1173 1180 O
active 32 38 1181 1187 O
infection 39 48 1188 1197 B-chronic_disease

Histologically 0 14 1198 1212 O
or 15 17 1213 1215 O
cytologically 18 31 1216 1229 O
confirmed 32 41 1230 1239 O
diagnosis 42 51 1240 1249 O
of 52 54 1250 1252 O
MCL 55 58 1253 1256 B-cancer

History 0 7 1257 1264 O
of 8 10 1265 1267 O
uncontrolled 11 23 1268 1280 O
arrhythmias 24 35 1281 1292 B-chronic_disease

History 0 7 1293 1300 O
of 8 10 1301 1303 O
uncontrolled 11 23 1304 1316 O
or 24 26 1317 1319 O
symptomatic 27 38 1320 1331 O
angina 39 45 1332 1338 B-chronic_disease

Known 0 5 1339 1344 O
human 6 11 1345 1350 B-chronic_disease
immunodeficiency 12 28 1351 1367 I-chronic_disease
virus 29 34 1368 1373 I-chronic_disease
( 35 36 1374 1375 I-chronic_disease
HIV-1 36 41 1375 1380 I-chronic_disease
) 41 42 1380 1381 I-chronic_disease
infection 43 52 1382 1391 I-chronic_disease
or 53 55 1392 1394 O
chronic 56 63 1395 1402 O
hepatitis 64 73 1403 1412 B-chronic_disease
B 74 75 1413 1414 I-chronic_disease
, 75 76 1414 1415 I-chronic_disease
or 77 79 1416 1418 I-chronic_disease
C 80 81 1419 1420 I-chronic_disease

Laboratory 0 10 1421 1431 O
tests 11 16 1432 1437 O
Required 17 25 1438 1446 O
value 26 31 1447 1452 O
WBC 32 35 1453 1456 B-clinical_variable
> 36 37 1457 1458 O
3000 37 41 1458 1462 B-lower_bound
/ 41 42 1462 1463 I-lower_bound
μL 42 44 1463 1465 I-lower_bound
* 44 45 1465 1466 O
Absolute 46 54 1467 1475 B-clinical_variable
neutrophils 55 66 1476 1487 I-clinical_variable
count 67 72 1488 1493 I-clinical_variable
> 73 74 1494 1495 O
1,000 74 79 1495 1500 B-lower_bound
/ 79 80 1500 1501 I-lower_bound
μL 80 82 1501 1503 I-lower_bound
* 82 83 1503 1504 O
Platelets 84 93 1505 1514 B-clinical_variable
> 94 95 1515 1516 O
75,000 95 101 1516 1522 B-lower_bound
/ 101 102 1522 1523 I-lower_bound
μL 102 104 1523 1525 I-lower_bound
Total 105 110 1526 1531 B-clinical_variable
bilirubin 111 120 1532 1541 I-clinical_variable
< 121 122 1542 1543 O
1.5Within 123 132 1544 1553 B-upper_bound
normal 133 139 1554 1560 I-upper_bound
institutional 140 153 1561 1574 I-upper_bound
limits 154 160 1575 1581 I-upper_bound
AST 161 164 1582 1585 B-clinical_variable
( 165 166 1586 1587 I-clinical_variable
SGOT 166 170 1587 1591 I-clinical_variable
) 170 171 1591 1592 I-clinical_variable
and 172 175 1593 1596 I-clinical_variable
ALT 176 179 1597 1600 I-clinical_variable
( 180 181 1601 1602 I-clinical_variable
SGPT 181 185 1602 1606 I-clinical_variable
) 185 186 1606 1607 I-clinical_variable
<3 187 189 1608 1610 O
x 190 191 1611 1612 I-upper_bound
institutional 192 205 1613 1626 I-upper_bound
upper 206 211 1627 1632 I-upper_bound
limit 212 217 1633 1638 I-upper_bound
of 218 220 1639 1641 I-upper_bound
normal 221 227 1642 1648 I-upper_bound
Creatinine 228 238 1649 1659 B-clinical_variable
or 239 241 1660 1662 I-clinical_variable
creatinine 242 252 1663 1673 I-clinical_variable
clearance 253 262 1674 1683 I-clinical_variable
< 263 264 1684 1685 O
1.5 264 267 1685 1688 B-upper_bound
within 268 274 1689 1695 I-upper_bound
normal 275 281 1696 1702 I-upper_bound
institutional 282 295 1703 1716 I-upper_bound
limits 296 302 1717 1723 I-upper_bound
> 303 304 1724 1725 O
60 304 306 1725 1727 B-lower_bound
mL 307 309 1728 1730 I-lower_bound
/ 309 310 1730 1731 I-lower_bound
min/1.73 310 318 1731 1739 I-lower_bound
m2 319 321 1740 1742 I-lower_bound
for 322 325 1743 1746 O
patients 326 334 1747 1755 O
with 335 339 1756 1760 O
creatinine 340 350 1761 1771 B-clinical_variable
levels 351 357 1772 1778 I-clinical_variable
above 358 363 1779 1784 O
institutional 364 377 1785 1798 O
normal 378 384 1799 1805 O
( 385 386 1806 1807 O
calculated 386 396 1807 1817 O
by 397 399 1818 1820 O
Cockcroft 400 409 1821 1830 O
- 409 410 1830 1831 O
Gault 410 415 1831 1836 O
formula 416 423 1837 1844 O
) 423 424 1844 1845 O

Major 0 5 1846 1851 B-treatment
surgery 6 13 1852 1859 I-treatment
or 14 16 1860 1862 O
significant 17 28 1863 1874 O
traumatic 29 38 1875 1884 B-chronic_disease
injury 39 45 1885 1891 I-chronic_disease
within 46 52 1892 1898 O
28 53 55 1899 1901 B-upper_bound
days 56 60 1902 1906 I-upper_bound
of 61 63 1907 1909 O
the 64 67 1910 1913 O
first 68 73 1914 1919 O
dose 74 78 1920 1924 O
of 79 81 1925 1927 O
study 82 87 1928 1933 B-treatment
drug 88 92 1934 1938 I-treatment

Myocardial 0 10 1939 1949 B-clinical_variable
infarction 11 21 1950 1960 I-clinical_variable
< 22 23 1961 1962 O
6 24 25 1963 1964 B-upper_bound
months 26 32 1965 1971 I-upper_bound
from 33 37 1972 1976 O
study 38 43 1977 1982 O
entry 44 49 1983 1988 O

Normal 0 6 1989 1995 O
renal 7 12 1996 2001 O
function 13 21 2002 2010 O
defined 22 29 2011 2018 O
as 30 32 2019 2021 O
serum 33 38 2022 2027 B-clinical_variable
creatinine 39 49 2028 2038 I-clinical_variable
less 50 54 2039 2043 O
than 55 59 2044 2048 O
2 60 61 2049 2050 B-upper_bound

Other 0 5 2051 2056 O
medical 6 13 2057 2064 B-chronic_disease
conditions 14 24 2065 2075 I-chronic_disease
that 25 29 2076 2080 O
would 30 35 2081 2086 O
potentially 36 47 2087 2098 O
interfere 48 57 2099 2108 O
with 58 62 2109 2113 O
patient 63 70 2114 2121 O
participation 71 84 2122 2135 O
in 85 87 2136 2138 O
this 88 92 2139 2143 O
trial 93 98 2144 2149 O

Patients 0 8 2150 2158 O
may 9 12 2159 2162 O
be 13 15 2163 2165 O
eligible 16 24 2166 2174 O
upon 25 29 2175 2179 O
resolution 30 40 2180 2190 O
of 41 43 2191 2193 O
the 44 47 2194 2197 O
infection 48 57 2198 2207 B-chronic_disease

Patients 0 8 2208 2216 O
who 9 12 2217 2220 O
have 13 17 2221 2225 O
previously 18 28 2226 2236 O
received 29 37 2237 2245 O
high 38 42 2246 2250 B-treatment
- 42 43 2250 2251 I-treatment
dose 43 47 2251 2255 I-treatment
chemotherapy 48 60 2256 2268 I-treatment
with 61 65 2269 2273 I-treatment
peripheral 66 76 2274 2284 I-treatment
stem 77 81 2285 2289 I-treatment
cell 82 86 2290 2294 I-treatment
support 87 94 2295 2302 I-treatment

Patients 0 8 2303 2311 O
with 9 13 2312 2316 O
grade 14 19 2317 2322 B-lower_bound
3/4 20 23 2323 2326 I-lower_bound
cardiac 24 31 2327 2334 O
problems 32 40 2335 2343 O

Platelets 0 9 2344 2353 B-clinical_variable
> 10 11 2354 2355 O
75,000 12 18 2356 2362 B-lower_bound
/ 18 19 2362 2363 I-lower_bound
μL 19 21 2363 2365 I-lower_bound
and 22 25 2366 2369 O
absolute 26 34 2370 2378 B-clinical_variable
neutrophils 35 46 2379 2390 I-clinical_variable
count 47 52 2391 2396 I-clinical_variable
( 53 54 2397 2398 I-clinical_variable
ANC 54 57 2398 2401 I-clinical_variable
) 57 58 2401 2402 I-clinical_variable
> 59 60 2403 2404 O
1,000 61 66 2405 2410 B-lower_bound
/ 66 67 2410 2411 I-lower_bound
μL 67 69 2411 2413 I-lower_bound
within 70 76 2414 2420 O
14 77 79 2421 2423 B-upper_bound
days 80 84 2424 2428 I-upper_bound
of 85 87 2429 2431 O
study 88 93 2432 2437 O
registration 94 106 2438 2450 O
( 107 108 2451 2452 O
unless 108 114 2452 2458 O
the 115 118 2459 2462 O
treating 119 127 2463 2471 O
physician 128 137 2472 2481 O
deems 138 143 2482 2487 O
the 144 147 2488 2491 O
neutropenia 148 159 2492 2503 B-chronic_disease
is 160 162 2504 2506 O
related 163 170 2507 2514 O
to 171 173 2515 2517 O
bone 174 178 2518 2522 O
marrow 179 185 2523 2529 O
involvement 186 197 2530 2541 O
, 197 198 2541 2542 O
then 199 203 2543 2547 O
an 204 206 2548 2550 O
ANC 207 210 2551 2554 O
of 211 213 2555 2557 O
> 214 215 2558 2559 O
750 216 219 2560 2563 B-lower_bound
/ 219 220 2563 2564 I-lower_bound
mm 220 222 2564 2566 I-lower_bound
3 223 224 2567 2568 I-lower_bound
is 225 227 2569 2571 O
allowed 228 235 2572 2579 O
) 235 236 2579 2580 O

Presence 0 8 2581 2589 O
of 9 11 2590 2592 O
at 12 14 2593 2595 O
least 15 20 2596 2601 O
one 21 24 2602 2605 B-lower_bound
lymph 25 30 2606 2611 O
node 31 35 2612 2616 O
evaluable 36 45 2617 2626 O
or 46 48 2627 2629 O
mass 49 53 2630 2634 B-chronic_disease
measurable 54 64 2635 2645 O
for 65 68 2646 2649 O
response 69 77 2650 2658 O

Recovery 0 8 2659 2667 O
from 9 13 2668 2672 O
any 14 17 2673 2676 O
previous 18 26 2677 2685 B-treatment
treatment 27 36 2686 2695 I-treatment
therapy 37 44 2696 2703 I-treatment

Relapsed 0 8 2704 2712 O
or 9 11 2713 2715 O
refractory 12 22 2716 2726 O
MCL 23 26 2727 2730 B-cancer
patients 27 35 2731 2739 O
who 36 39 2740 2743 O
have 40 44 2744 2748 O
received 45 53 2749 2757 O
at 54 56 2758 2760 O
least 57 62 2761 2766 O
one 63 66 2767 2770 B-lower_bound
prior 67 72 2771 2776 B-treatment
therapy 73 80 2777 2784 I-treatment

Uncontrolled 0 12 2785 2797 O
or 13 15 2798 2800 O
symptomatic 16 27 2801 2812 O
congestive 28 38 2813 2823 B-chronic_disease
heart 39 44 2824 2829 I-chronic_disease
failure 45 52 2830 2837 I-chronic_disease

Use 0 3 2838 2841 O
of 4 6 2842 2844 O
any 7 10 2845 2848 O
other 11 16 2849 2854 O
standard 17 25 2855 2863 B-treatment
chemotherapy 26 38 2864 2876 I-treatment
, 38 39 2876 2877 O
radiation 40 49 2878 2887 B-treatment
therapy 50 57 2888 2895 I-treatment
, 57 58 2895 2896 O
or 59 61 2897 2899 O
experimental 62 74 2900 2912 B-treatment
drug 75 79 2913 2917 I-treatment
therapy 80 87 2918 2925 I-treatment
for 88 91 2926 2929 O
the 92 95 2930 2933 O
treatment 96 105 2934 2943 B-treatment
of 106 108 2944 2946 O
MCL 109 112 2947 2950 B-cancer
within 113 119 2951 2957 O
21 120 122 2958 2960 B-upper_bound
days 123 127 2961 2965 I-upper_bound
of 128 130 2966 2968 O
starting 131 139 2969 2977 O
treatment 140 149 2978 2987 O
or 150 152 2988 2990 O
5 153 154 2991 2992 O
half 155 159 2993 2997 O
life 160 164 2998 3002 O
times 165 170 3003 3008 O
( 171 172 3009 3010 O
whatever 172 180 3010 3018 O
is 181 183 3019 3021 O
shorter 184 191 3022 3029 O
) 191 192 3029 3030 O

